Darren R. Carpizo, Ph.D.
Affiliations: | 2003 | University of California, Los Angeles, Los Angeles, CA |
Area:
Molecular Biology, Medicine and SurgeryGoogle:
"Darren Carpizo"Parents
Sign in to add mentorLuisa Iruela-Arispe | grad student | 2003 | UCLA | |
(ADAMTS -1 /METH -1: A matrix metalloprotease that regulates tumor growth and angiogenesis by selective shedding of cell surface proteins.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Langan RC, Carpizo DR. (2019) Modernizing the clinical risk score to more accurately predict survival following resection of colorectal liver metastases. Translational Gastroenterology and Hepatology. 4: 49 |
Zaman S, Yu X, Bencivenga AF, et al. (2019) Combinatorial therapy of Zinc metallochaperones with mutant p53 reactivation and diminished copper binding. Molecular Cancer Therapeutics |
Ali ND, Donohue K, Zandieh S, et al. (2019) Conditional Survival Analysis of Metastatic Colorectal Cancer Patients Living ≥24 Months: A Single Institutional Study. American Journal of Clinical Oncology |
Yu X, Carpizo DR. (2019) Flipping the "switch" on mutant p53 by zinc metallochaperones: how a brief pulse of zinc can reactivate mutant p53 to kill cancer. Oncotarget. 10: 918-919 |
Na B, Yu X, Wither T, et al. (2019) Abstract P6-20-05: Therapeutic targeting ofBRCA1andTP53mutant breast cancer through mutant p53 reactivation Cancer Research |
Shah MM, Rhee K, NeMoyer RE, et al. (2019) Conditional survival of patients with hepatocellular carcinoma undergoing curative intent resection: Analysis of the national cancer database Hpb. 21 |
Yu X, Kogan S, Chen Y, et al. (2018) Zinc Metallochaperones Reactivate Mutant p53 Using an ON/OFF Switch Mechanism: A New Paradigm in Cancer Therapeutics. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research |
Kogan S, Carpizo DR. (2018) Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics. Cancers. 10 |
Weiner AA, Gui B, Newman NB, et al. (2018) Predictors of Survival after Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases. Journal of Vascular and Interventional Radiology : Jvir |
Chang H, Xiao Z, Li T, et al. (2018) Abstract 2881: RET signaling in pancreatic cancer: A novel target by metformin to suppress cancer progression Cancer Research. 78: 2881-2881 |